Prosecution Insights
Last updated: November 20, 2026

Robert James Kallal, USPTO Patent Examiner

Listed by the USPTO as KALLAL, ROBERT JAMES

Tech Center 2800 • Art Units: 1651 1671 1683 1685 1699 2146 2863

This examiner grants 59% of resolved cases

Analysis

KALLAL, ROBERT JAMES is a USPTO patent examiner in Technology Center 2800 and art unit 1651. The profile includes 104 resolved cases, an allowance rate of 58.7%, and an interview lift of 29.9%. The median time to allowance is 1529 days.

The top companies are Washington University, Board of Regents of the University of Texas System, and Fujifilm Holdings Corporation. The top firms are MARSHALL, GERSTEIN & BORUN LLP, NORTON ROSE FULBRIGHT US LLP, and BIRCH STEWART KOLASCH & BIRCH, LLP. The positive interview association supports preparing for examiner discussion where it can narrow the dispute. The median timing indicates that applicants should set expectations for extended prosecution and maintain a response plan beyond the first amendment cycle.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

58.7%
Allow Rate
-9.3% vs TC avg
157
Total Applications
+29.9%
Interview Lift
1529
Avg Prosecution Days
Based on 104 resolved cases, 2023–2026

Rejection Statute Breakdown

36.1%
§101 Eligibility
7.7%
§102 Novelty
29.2%
§103 Obviousness
22.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
16850838 FEATURE QUANTITY CALCULATING METHOD, FEATURE QUANTITY CALCULATING PROGRAM, AND FEATURE QUANTITY CALCULATING DEVICE, SCREENING METHOD, SCREENING PROGRAM, AND SCREENING DEVICE, COMPOUND CREATING METHOD, COMPOUND CREATING PROGRAM, AND COMPOUND CREATING DEVICE Final Rejection FUJIFILM Corporation
18265795 STRUCTURAL VARIANT EVALUATION THROUGH ITERATIVE GENOME CONSTRUCTION Non-Final OA GOOGLE LLC
17985098 IDENTIFYING POOR CARDIORESPIRATORY FITNESS USING SENSORS OF WEARABLE DEVICES Non-Final OA Apple Inc.
18507058 Method and Apparatus for Reconstructing the Position of Cells in a Three-Dimensional Tissue Non-Final OA Robert Bosch GmbH
17354992 METHOD AND DEVICE FOR ASCERTAINING AN RNA SEQUENCE Final Rejection Robert Bosch GmbH
18289484 METHODS AND SYSTEMS FOR THE CLASSIFICATION OF SUBJECTS INTO GLUCOSE HOMEOSTASIS PHENOTYPES Non-Final OA KVI Brave Fund I Inc.
18550797 SPECTRAL CORRELATION ANALYSIS OF LAYERED EVOLUTIONARY SIGNALS Non-Final OA Washington University
18298355 UNSUPERVISED DISCOVERY OF TUMOR MICROENVIRONMENTAL COMMUNITIES Non-Final OA Washington University
17123591 METHODS, SYSTEMS, AND RELATED COMPUTER PROGRAM PRODUCTS FOR EVALUATING CANCER MODEL FIDELITY Final Rejection THE JOHNS HOPKINS UNIVERSITY
18348930 Human Therapeutic Targets and Modulators Thereof Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18469665 INTERNET-OF-THINGS-BASED ALLERGEN POLLEN CONCENTRATION PREDICTION Non-Final OA INTERNATIONAL BUSINESS MACHINES CORPORATION
18256442 METHODS AND SYSTEMS FOR SELECTING CONDITIONS FOR MAKING INHALATION FORMULATIONS Non-Final OA Board of Regents, The University of Texas System
17440993 COMPUTERIZED SYSTEM AND METHOD FOR ANTIGEN-INDEPENDENT DE NOVO PREDICTION OF CANCER-ASSOCIATED TCR REPERTOIRE Non-Final OA Board of Regents of the University of Texas System
17574921 SENSING OF BIOLOGICAL CELLS IN A SAMPLE FOR CELL TYPE IDENTIFICATION Final Rejection Sanofi
19020349 METHODS AND SYSTEMS FOR DETERMINING CIRCULATING TUMOR DNA FRACTION IN A PATIENT SAMPLE Non-Final OA Foundation Medicine, Inc.
17805138 SIGNAL-TO-NOISE-RATIO METRIC FOR DETERMINING NUCLEOTIDE-BASE CALLS AND BASE-CALL QUALITY Final Rejection Illumina, Inc.
17736495 SYSTEMS AND METHODS FOR ASSESSING A BACTERIAL OR VIRAL STATUS OF A SAMPLE Non-Final OA Inflammatix, Inc.
17817421 SOMATIC VARIANT COOCCURRENCE WITH ABNORMALLY METHYLATED FRAGMENTS Final Rejection GRAIL, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Robert James Kallal's allowance rate?

58.7% of resolved applications examined by Robert James Kallal were allowed (104 resolved cases), compared with 31.5% across Art Unit 1651 over the last five years.

Does an interview help with examiner Robert James Kallal?

This examiner's interview lift is +29.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Robert James Kallal take to allow a patent?

Applications allowed by Robert James Kallal took 1,529 days on average from filing to allowance.

Which art unit does examiner Robert James Kallal work in?

Robert James Kallal examines applications in Art Unit 1651 in Tech Center 2800 (Semiconductors, Circuits & Optics).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month